ID   DPOD2_HUMAN             Reviewed;         469 AA.
AC   P49005; A4D2J4; B2R5S4;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   15-MAR-2017, entry version 167.
DE   RecName: Full=DNA polymerase delta subunit 2;
DE   AltName: Full=DNA polymerase delta subunit p50;
GN   Name=POLD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8530069; DOI=10.1006/geno.1995.1229;
RA   Zhang J., Tan C.-K., McMullen B., Downey K.M., So A.G.;
RT   "Cloning of the cDNAs for the small subunits of bovine and human DNA
RT   polymerase delta and chromosomal location of the human gene (POLD2).";
RL   Genomics 29:179-186(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10978529; DOI=10.1016/S0167-4781(00)00153-6;
RA   Perez A., Leon A., Lee M.Y.W.T.;
RT   "Characterization of the 5'-flanking region of the gene encoding the
RT   50 kDa subunit of human DNA polymerase delta.";
RL   Biochim. Biophys. Acta 1493:231-236(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-303.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH POLD1 AND POLD3.
RX   PubMed=11328591; DOI=10.1093/oxfordjournals.jbchem.a002909;
RA   Shikata K., Ohta S., Yamada K., Obuse C., Yoshikawa H., Tsurimoto T.;
RT   "The human homologue of fission Yeast cdc27, p66, is a component of
RT   active human DNA polymerase delta.";
RL   J. Biochem. 129:699-708(2001).
RN   [9]
RP   INTERACTION WITH KCTD13.
RX   PubMed=11593007; DOI=10.1073/pnas.221452098;
RA   He H., Tan C.-K., Downey K.M., So A.G.;
RT   "A tumor necrosis factor alpha- and interleukin 6-inducible protein
RT   that interacts with the small subunit of DNA polymerase delta and
RT   proliferating cell nuclear antigen.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:11979-11984(2001).
RN   [10]
RP   FUNCTION, CHARACTERIZATION OF POL-DELTA2 AND POL-DELTA4 COMPLEXES, AND
RP   LACK OF INTERACTION WITH PCNA.
RX   PubMed=12403614; DOI=10.1021/bi0262707;
RA   Xie B., Mazloum N., Liu L., Rahmeh A., Li H., Lee M.Y.;
RT   "Reconstitution and characterization of the human DNA polymerase delta
RT   four-subunit holoenzyme.";
RL   Biochemistry 41:13133-13142(2002).
RN   [11]
RP   INTERACTION WITH POLD1; POLDIP2 AND POLDIP3.
RX   PubMed=12522211; DOI=10.1074/jbc.M208694200;
RA   Liu L., Rodriguez-Belmonte E.M., Mazloum N., Xie B., Lee M.Y.W.T.;
RT   "Identification of a novel protein, PDIP38, that interacts with the
RT   p50 subunit of DNA polymerase delta and proliferating cell nuclear
RT   antigen.";
RL   J. Biol. Chem. 278:10041-10047(2003).
RN   [12]
RP   INTERACTION WITH WRNIP1.
RX   PubMed=15670210; DOI=10.1111/j.1365-2443.2004.00812.x;
RA   Tsurimoto T., Shinozaki A., Yano M., Seki M., Enomoto T.;
RT   "Human Werner helicase interacting protein 1 (WRNIP1) functions as a
RT   novel modulator for DNA polymerase delta.";
RL   Genes Cells 10:13-22(2005).
RN   [13]
RP   FUNCTION, INTERACTION WITH POLD1; POLD3 AND POLD4, AND LACK OF
RP   INTERACTION WITH PCNA.
RX   PubMed=16510448; DOI=10.1074/jbc.M600322200;
RA   Li H., Xie B., Zhou Y., Rahmeh A., Trusa S., Zhang S., Gao Y.,
RA   Lee E.Y., Lee M.Y.;
RT   "Functional roles of p12, the fourth subunit of human DNA polymerase
RT   delta.";
RL   J. Biol. Chem. 281:14748-14755(2006).
RN   [14]
RP   IDENTIFICATION IN POL-DELTA COMPLEX.
RX   PubMed=17317665; DOI=10.1074/jbc.M610356200;
RA   Zhang S., Zhou Y., Trusa S., Meng X., Lee E.Y., Lee M.Y.;
RT   "A novel DNA damage response: rapid degradation of the p12 subunit of
RT   dna polymerase delta.";
RL   J. Biol. Chem. 282:15330-15340(2007).
RN   [15]
RP   FUNCTION, AND CHARACTERIZATION OF POL-DELTA3 AND POL-DELTA4.
RX   PubMed=19074196; DOI=10.1093/nar/gkn1000;
RA   Meng X., Zhou Y., Zhang S., Lee E.Y., Frick D.N., Lee M.Y.;
RT   "DNA damage alters DNA polymerase delta to a form that exhibits
RT   increased discrimination against modified template bases and
RT   mismatched primers.";
RL   Nucleic Acids Res. 37:647-657(2009).
RN   [16]
RP   FUNCTION, AND IDENTIFICATION IN POL-DELTA COMPLEX.
RX   PubMed=20334433; DOI=10.1021/bi100042b;
RA   Meng X., Zhou Y., Lee E.Y., Lee M.Y., Frick D.N.;
RT   "The p12 subunit of human polymerase delta modulates the rate and
RT   fidelity of DNA synthesis.";
RL   Biochemistry 49:3545-3554(2010).
RN   [17]
RP   FUNCTION IN NUCLEOTIDE EXCISION REPAIR.
RX   PubMed=20227374; DOI=10.1016/j.molcel.2010.02.009;
RA   Ogi T., Limsirichaikul S., Overmeer R.M., Volker M., Takenaka K.,
RA   Cloney R., Nakazawa Y., Niimi A., Miki Y., Jaspers N.G.,
RA   Mullenders L.H., Yamashita S., Fousteri M.I., Lehmann A.R.;
RT   "Three DNA polymerases, recruited by different mechanisms, carry out
RT   NER repair synthesis in human cells.";
RL   Mol. Cell 37:714-727(2010).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   SUBCELLULAR LOCATION, IDENTIFICATION IN POL-DELTA COMPLEX, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=22801543; DOI=10.4161/cc.21280;
RA   Chea J., Zhang S., Zhao H., Zhang Z., Lee E.Y., Darzynkiewicz Z.,
RA   Lee M.Y.;
RT   "Spatiotemporal recruitment of human DNA polymerase delta to sites of
RT   UV damage.";
RL   Cell Cycle 11:2885-2895(2012).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [23]
RP   FUNCTION IN OKAZAKI FRAGMENT PROCESSING.
RX   PubMed=24035200; DOI=10.1016/j.dnarep.2013.08.008;
RA   Lin S.H., Wang X., Zhang S., Zhang Z., Lee E.Y., Lee M.Y.;
RT   "Dynamics of enzymatic interactions during short flap human Okazaki
RT   fragment processing by two forms of human DNA polymerase delta.";
RL   DNA Repair 12:922-935(2013).
RN   [24]
RP   POL-DELTA3 COMPLEX EXPRESSION DURING CELL CYCLE.
RX   PubMed=23913683; DOI=10.1074/jbc.M113.490466;
RA   Zhang S., Zhao H., Darzynkiewicz Z., Zhou P., Zhang Z., Lee E.Y.,
RA   Lee M.Y.;
RT   "A novel function of CRL4(Cdt2): regulation of the subunit structure
RT   of DNA polymerase delta in response to DNA damage and during the S
RT   phase.";
RL   J. Biol. Chem. 288:29550-29561(2013).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15 AND SER-257, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   FUNCTION, IDENTIFICATION IN POL-DELTA COMPLEX, AND IDENTIFICATION IN
RP   COMPLEX WITH REV3L; MAD2L2 AND POLD3.
RX   PubMed=24449906; DOI=10.1073/pnas.1324001111;
RA   Lee Y.S., Gregory M.T., Yang W.;
RT   "Human Pol zeta purified with accessory subunits is active in
RT   translesion DNA synthesis and complements Pol eta in cisplatin
RT   bypass.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:2954-2959(2014).
RN   [27]
RP   FUNCTION IN BIR.
RX   PubMed=24310611; DOI=10.1126/science.1243211;
RA   Costantino L., Sotiriou S.K., Rantala J.K., Magin S., Mladenov E.,
RA   Helleday T., Haber J.E., Iliakis G., Kallioniemi O.P.,
RA   Halazonetis T.D.;
RT   "Break-induced replication repair of damaged forks induces genomic
RT   duplications in human cells.";
RL   Science 343:88-91(2014).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) IN COMPLEX WITH POLD3, AND
RP   MUTAGENESIS OF LEU-217; GLY-224 AND GLU-231.
RX   PubMed=18818516; DOI=10.4161/cc.7.19.6720;
RA   Baranovskiy A.G., Babayeva N.D., Liston V.G., Rogozin I.B.,
RA   Koonin E.V., Pavlov Y.I., Vassylyev D.G., Tahirov T.H.;
RT   "X-ray structure of the complex of regulatory subunits of human DNA
RT   polymerase delta.";
RL   Cell Cycle 7:3026-3036(2008).
CC   -!- FUNCTION: As a component of the trimeric and tetrameric DNA
CC       polymerase delta complexes (Pol-delta3 and Pol-delta4,
CC       respectively), plays a role in high fidelity genome replication,
CC       including in lagging strand synthesis, and repair
CC       (PubMed:12403614, PubMed:16510448, PubMed:19074196,
CC       PubMed:20334433, PubMed:24035200). Pol-delta3 and Pol-delta4 are
CC       characterized by the absence or the presence of POLD4. They
CC       exhibit differences in catalytic activity. Most notably, Pol-
CC       delta3 shows higher proofreading activity than Pol-delta4
CC       (PubMed:19074196, PubMed:20334433). Although both Pol-delta3 and
CC       Pol-delta4 process Okazaki fragments in vitro, Pol-delta3 may also
CC       be better suited to fulfill this task, exhibiting near-absence of
CC       strand displacement activity compared to Pol-delta4 and stalling
CC       on encounter with the 5'-blocking oligonucleotides. Pol-delta3
CC       idling process may avoid the formation of a gap, while maintaining
CC       a nick that can be readily ligated (PubMed:24035200). Along with
CC       DNA polymerase kappa, DNA polymerase delta carries out
CC       approximately half of nucleotide excision repair (NER) synthesis
CC       following UV irradiation (PubMed:20227374). Under conditions of
CC       DNA replication stress, required for the repair of broken
CC       replication forks through break-induced replication (BIR)
CC       (PubMed:24310611). Involved in the translesion synthesis (TLS) of
CC       templates carrying O6-methylguanine or abasic sites performed by
CC       Pol-delta4, independently of DNA polymerase zeta (REV3L) or eta
CC       (POLH). Facilitates abasic site bypass by DNA polymerase delta by
CC       promoting extension from the nucleotide inserted opposite the
CC       lesion. Also involved in TLS as a component of the POLZ complex.
CC       Along with POLD3, dramatically increases the efficiency and
CC       processivity of DNA synthesis of the minimal DNA polymerase zeta
CC       complex, consisting of only REV3L and REV7 (PubMed:24449906).
CC       {ECO:0000269|PubMed:12403614, ECO:0000269|PubMed:16510448,
CC       ECO:0000269|PubMed:19074196, ECO:0000269|PubMed:20227374,
CC       ECO:0000269|PubMed:20334433, ECO:0000269|PubMed:24035200,
CC       ECO:0000269|PubMed:24310611, ECO:0000269|PubMed:24449906}.
CC   -!- SUBUNIT: Component of the tetrameric DNA polymerase delta complex
CC       (Pol-delta4), which consists of POLD1/p125, POLD2/p50,
CC       POLD3/p66/p68 and POLD4/p12, with POLD1 bearing DNA polymerase and
CC       3' to 5' proofreading exonuclease activities (PubMed:22801543,
CC       PubMed:17317665). Within Pol-delta4, directly interacts with
CC       POLD1, POLD3 and POLD4 (PubMed:11328591, PubMed:16510448).
CC       Following stress caused by DNA damaging agents or by replication
CC       stress, POLD4 is degraded and Pol-delta4 is converted into a
CC       trimeric form of the complex (Pol-delta3), which consists of
CC       POLD1, POLD2 and POLD3. Pol-delta3 is the major form occurring at
CC       S phase replication sites, as well as DNA damage sites
CC       (PubMed:22801543, PubMed:17317665). Also observed as a dimeric
CC       complex with POLD2 (Pol-delta2 complex). Pol-delta2 is relatively
CC       insensitive to the PCNA stimulation (2-5-fold) compared to Pol-
CC       delta4 that is stimulated by over 50-fold (PubMed:12403614).
CC       Contrary to the other components of Pol-delta4, does not directly
CC       interact with PCNA (PubMed:12403614, PubMed:16510448). As POLD1
CC       and POLD4, directly interacts with WRNIP1; this interaction
CC       stimulates DNA polymerase delta-mediated DNA synthesis,
CC       independently of the presence of PCNA. This stimulation may be due
CC       predominantly to an increase of initiation frequency and also to
CC       increased processivity (PubMed:15670210). Directly interacts with
CC       POLDIP2 and POLDIP3 (PubMed:12522211). Directly interacts with
CC       KCTD13/PDIP1; in the presence of PCNA, this interaction may
CC       stimulate DNA polymerase activity (PubMed:11593007). Component of
CC       the DNA polymerase zeta complex (POLZ), which consists of REV3L,
CC       MAD2L2, POLD2 and POLD3, with REV3L bearing DNA polymerase
CC       catalytic activity (PubMed:24449906). Interacts with KCTD10 (By
CC       similarity). {ECO:0000250|UniProtKB:Q7TPL3,
CC       ECO:0000269|PubMed:11328591, ECO:0000269|PubMed:11593007,
CC       ECO:0000269|PubMed:12403614, ECO:0000269|PubMed:12522211,
CC       ECO:0000269|PubMed:15670210, ECO:0000269|PubMed:16510448,
CC       ECO:0000269|PubMed:17317665, ECO:0000269|PubMed:22801543,
CC       ECO:0000269|PubMed:24449906}.
CC   -!- INTERACTION:
CC       P12004:PCNA; NbExp=2; IntAct=EBI-372354, EBI-358311;
CC       P28340:POLD1; NbExp=10; IntAct=EBI-372354, EBI-716569;
CC       Q15054:POLD3; NbExp=5; IntAct=EBI-372354, EBI-864956;
CC       Q9HCU8:POLD4; NbExp=3; IntAct=EBI-372354, EBI-864968;
CC       Q96S55:WRNIP1; NbExp=2; IntAct=EBI-372354, EBI-2513471;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22801543}.
CC       Note=Recruited to DNA damage sites within 2 hours following UV
CC       irradiation. {ECO:0000269|PubMed:22801543}.
CC   -!- DEVELOPMENTAL STAGE: Expression is cell cycle-dependent, with
CC       highest levels in G2/M phase and lowest in S.
CC       {ECO:0000269|PubMed:22801543}.
CC   -!- SIMILARITY: Belongs to the DNA polymerase delta/II small subunit
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/pold2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U21090; AAC50216.1; -; mRNA.
DR   EMBL; AF239710; AAG09763.1; -; Genomic_DNA.
DR   EMBL; AY116646; AAM51148.1; -; Genomic_DNA.
DR   EMBL; AK292347; BAF85036.1; -; mRNA.
DR   EMBL; AK312294; BAG35221.1; -; mRNA.
DR   EMBL; CH236960; EAL23767.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW61118.1; -; Genomic_DNA.
DR   EMBL; BC000459; AAH00459.1; -; mRNA.
DR   CCDS; CCDS5477.1; -.
DR   PIR; I38950; I38950.
DR   RefSeq; NP_001120690.1; NM_001127218.2.
DR   RefSeq; NP_001243808.1; NM_001256879.1.
DR   RefSeq; NP_006221.2; NM_006230.3.
DR   UniGene; Hs.306791; -.
DR   UniGene; Hs.740138; -.
DR   PDB; 3E0J; X-ray; 3.00 A; A/C/E/G=1-469.
DR   PDBsum; 3E0J; -.
DR   ProteinModelPortal; P49005; -.
DR   SMR; P49005; -.
DR   BioGrid; 111421; 31.
DR   IntAct; P49005; 17.
DR   STRING; 9606.ENSP00000386105; -.
DR   iPTMnet; P49005; -.
DR   PhosphoSitePlus; P49005; -.
DR   BioMuta; POLD2; -.
DR   DMDM; 1352307; -.
DR   EPD; P49005; -.
DR   MaxQB; P49005; -.
DR   PaxDb; P49005; -.
DR   PeptideAtlas; P49005; -.
DR   PRIDE; P49005; -.
DR   DNASU; 5425; -.
DR   Ensembl; ENST00000406581; ENSP00000386105; ENSG00000106628.
DR   Ensembl; ENST00000452185; ENSP00000395231; ENSG00000106628.
DR   GeneID; 5425; -.
DR   KEGG; hsa:5425; -.
DR   UCSC; uc010kxz.5; human.
DR   CTD; 5425; -.
DR   DisGeNET; 5425; -.
DR   GeneCards; POLD2; -.
DR   HGNC; HGNC:9176; POLD2.
DR   HPA; HPA026745; -.
DR   MIM; 600815; gene.
DR   neXtProt; NX_P49005; -.
DR   OpenTargets; ENSG00000106628; -.
DR   PharmGKB; PA33497; -.
DR   eggNOG; KOG2732; Eukaryota.
DR   eggNOG; COG1311; LUCA.
DR   GeneTree; ENSGT00390000006780; -.
DR   HOGENOM; HOG000189057; -.
DR   HOVERGEN; HBG051396; -.
DR   InParanoid; P49005; -.
DR   KO; K02328; -.
DR   PhylomeDB; P49005; -.
DR   TreeFam; TF101073; -.
DR   Reactome; R-HSA-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-HSA-174411; Polymerase switching on the C-strand of the telomere.
DR   Reactome; R-HSA-174414; Processive synthesis on the C-strand of the telomere.
DR   Reactome; R-HSA-174417; Telomere C-strand (Lagging Strand) Synthesis.
DR   Reactome; R-HSA-174437; Removal of the Flap Intermediate from the C-strand.
DR   Reactome; R-HSA-5358565; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha).
DR   Reactome; R-HSA-5358606; Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta).
DR   Reactome; R-HSA-5651801; PCNA-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-HSA-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5696397; Gap-filling DNA repair synthesis and ligation in GG-NER.
DR   Reactome; R-HSA-5696400; Dual Incision in GG-NER.
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-69091; Polymerase switching.
DR   Reactome; R-HSA-69166; Removal of the Flap Intermediate.
DR   Reactome; R-HSA-69183; Processive synthesis on the lagging strand.
DR   ChiTaRS; POLD2; human.
DR   EvolutionaryTrace; P49005; -.
DR   GeneWiki; POLD2; -.
DR   GenomeRNAi; 5425; -.
DR   PRO; PR:P49005; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000106628; -.
DR   CleanEx; HS_POLD2; -.
DR   ExpressionAtlas; P49005; baseline and differential.
DR   Genevisible; P49005; HS.
DR   GO; GO:0043625; C:delta DNA polymerase complex; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; TAS:Reactome.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IBA:GO_Central.
DR   GO; GO:0042769; P:DNA damage response, detection of DNA damage; TAS:Reactome.
DR   GO; GO:0006266; P:DNA ligation; TAS:Reactome.
DR   GO; GO:0006260; P:DNA replication; TAS:ProtInc.
DR   GO; GO:0006271; P:DNA strand elongation involved in DNA replication; IBA:GO_Central.
DR   GO; GO:0006298; P:mismatch repair; TAS:Reactome.
DR   GO; GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome.
DR   GO; GO:0033683; P:nucleotide-excision repair, DNA incision; TAS:Reactome.
DR   GO; GO:0006296; P:nucleotide-excision repair, DNA incision, 5'-to lesion; TAS:Reactome.
DR   GO; GO:0000723; P:telomere maintenance; TAS:Reactome.
DR   GO; GO:0000722; P:telomere maintenance via recombination; TAS:Reactome.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   GO; GO:0019985; P:translesion synthesis; TAS:Reactome.
DR   InterPro; IPR007185; DNA_pol_alpha/epsilon_bsu.
DR   InterPro; IPR024826; DNA_pol_delta/II_ssu.
DR   PANTHER; PTHR10416; PTHR10416; 1.
DR   Pfam; PF04042; DNA_pol_E_B; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; DNA damage;
KW   DNA excision; DNA repair; DNA replication; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   CHAIN         1    469       DNA polymerase delta subunit 2.
FT                                /FTId=PRO_0000096166.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES      15     15       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     257    257       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     303    303       N -> S (in dbSNP:rs3087366).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_014885.
FT   MUTAGEN     217    217       L->W: Loss of POLD3-binding in a yeast
FT                                two-hybrid assay.
FT                                {ECO:0000269|PubMed:18818516}.
FT   MUTAGEN     224    224       G->W: Loss of POLD3-binding in a yeast
FT                                two-hybrid assay.
FT                                {ECO:0000269|PubMed:18818516}.
FT   MUTAGEN     231    231       E->W: Loss of POLD3-binding in a yeast
FT                                two-hybrid assay.
FT                                {ECO:0000269|PubMed:18818516}.
FT   CONFLICT    271    271       A -> T (in Ref. 4; BAG35221).
FT                                {ECO:0000305}.
FT   HELIX         2      7       {ECO:0000244|PDB:3E0J}.
FT   STRAND       13     16       {ECO:0000244|PDB:3E0J}.
FT   STRAND       32     34       {ECO:0000244|PDB:3E0J}.
FT   HELIX        37     39       {ECO:0000244|PDB:3E0J}.
FT   HELIX        55     72       {ECO:0000244|PDB:3E0J}.
FT   STRAND       82     84       {ECO:0000244|PDB:3E0J}.
FT   STRAND       91    100       {ECO:0000244|PDB:3E0J}.
FT   STRAND      132    136       {ECO:0000244|PDB:3E0J}.
FT   STRAND      141    147       {ECO:0000244|PDB:3E0J}.
FT   TURN        150    152       {ECO:0000244|PDB:3E0J}.
FT   STRAND      158    165       {ECO:0000244|PDB:3E0J}.
FT   STRAND      169    177       {ECO:0000244|PDB:3E0J}.
FT   STRAND      195    199       {ECO:0000244|PDB:3E0J}.
FT   HELIX       209    223       {ECO:0000244|PDB:3E0J}.
FT   HELIX       229    235       {ECO:0000244|PDB:3E0J}.
FT   STRAND      238    245       {ECO:0000244|PDB:3E0J}.
FT   HELIX       265    287       {ECO:0000244|PDB:3E0J}.
FT   STRAND      292    295       {ECO:0000244|PDB:3E0J}.
FT   STRAND      300    302       {ECO:0000244|PDB:3E0J}.
FT   STRAND      304    307       {ECO:0000244|PDB:3E0J}.
FT   HELIX       317    320       {ECO:0000244|PDB:3E0J}.
FT   STRAND      325    327       {ECO:0000244|PDB:3E0J}.
FT   STRAND      330    336       {ECO:0000244|PDB:3E0J}.
FT   STRAND      339    343       {ECO:0000244|PDB:3E0J}.
FT   HELIX       347    355       {ECO:0000244|PDB:3E0J}.
FT   HELIX       361    370       {ECO:0000244|PDB:3E0J}.
FT   STRAND      400    409       {ECO:0000244|PDB:3E0J}.
FT   STRAND      411    416       {ECO:0000244|PDB:3E0J}.
FT   STRAND      422    429       {ECO:0000244|PDB:3E0J}.
FT   HELIX       431    434       {ECO:0000244|PDB:3E0J}.
FT   STRAND      436    441       {ECO:0000244|PDB:3E0J}.
FT   TURN        442    445       {ECO:0000244|PDB:3E0J}.
FT   STRAND      449    454       {ECO:0000244|PDB:3E0J}.
FT   TURN        460    462       {ECO:0000244|PDB:3E0J}.
SQ   SEQUENCE   469 AA;  51289 MW;  389EF730999755AC CRC64;
     MFSEQAAQRA HTLLSPPSAN NATFARVPVA TYTNSSQPFR LGERSFSRQY AHIYATRLIQ
     MRPFLENRAQ QHWGSGVGVK KLCELQPEEK CCVVGTLFKA MPLQPSILRE VSEEHNLLPQ
     PPRSKYIHPD DELVLEDELQ RIKLKGTIDV SKLVTGTVLA VFGSVRDDGK FLVEDYCFAD
     LAPQKPAPPL DTDRFVLLVS GLGLGGGGGE SLLGTQLLVD VVTGQLGDEG EQCSAAHVSR
     VILAGNLLSH STQSRDSINK AKYLTKKTQA ASVEAVKMLD EILLQLSASV PVDVMPGEFD
     PTNYTLPQQP LHPCMFPLAT AYSTLQLVTN PYQATIDGVR FLGTSGQNVS DIFRYSSMED
     HLEILEWTLR VRHISPTAPD TLGCYPFYKT DPFIFPECPH VYFCGNTPSF GSKIIRGPED
     QTVLLVTVPD FSATQTACLV NLRSLACQPI SFSGFGAEDD DLGGLGLGP
//
